The clinical predictor of antitumor efficacy of cetuximab retreatment in patients with metastatic colorectal cancer who had a clinical benefit in response to prior cetuximab based regimen
The clinical predictor of antitumor efficacy of cetuximab retreatment in patients with metastatic colorectal cancer who had a clinical benefit in response to prior cetuximab based regimen
复制标题
西妥昔单抗再治疗对先前基于西妥昔单抗的方案有临床获益的转移性结直肠癌患者抗肿瘤疗效的临床预测因子
DOI：
--
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Takeshi Nagasaka,
中科院分区：
文献类型：
--
作者：
Hiroaki Tanioka;Motoi Asano;Ryousuke Yoshida;Naohisa Waki;Masahiro Ishizaki;Kazuki Yamashita;Yoshiko Mori;Takeshi Nagasaka,
